Oddity Tech has constructed a direct-to-consumer platform that leverages customer data to drive a recurring revenue flywheel. Since launching its first two beauty brands in 2022 and 2023, the company has achieved a repeat-purchase rate that climbed from 28% in Q1 2024 to 36% by Q3 2025. By collecting browsing behavior and purchase history across its website and mobile app, Oddity refines product launches: its latest serum introduced in July 2025 saw 120,000 units sold in the first month, outperforming initial forecasts by 45%. This data-driven model has enabled Oddity to maintain a gross margin of 73.13% while reducing customer-acquisition costs by 18% year-over-year.

In November 2025, Oddity expanded into dermatology with Methodiq, a telehealth offering targeting acne, hyperpigmentation and eczema. Methodiq integrates AI-powered skin analysis and computer-vision tracking to deliver personalized treatment plans. The platform debuted with 28 core products featuring proprietary, biotech-sourced active ingredients and offers over 100 distinct regimens. Early adoption metrics indicate 50,000 registered users and a 42% conversion rate from consultation to subscription within six weeks of launch, positioning Methodiq as a potential high-margin growth driver.

Oddity Tech reported a market capitalization of $2.2 billion as of mid-December 2025, with average daily trading volume near 893,000 shares. The company closed Q3 2025 with quarterly revenue of $185 million, up 62% year-over-year, while reducing operating expenses as a percentage of sales from 48% to 43%. Oddity’s balance sheet shows $150 million in cash and equivalents, supporting further brand launches and technology investments through 2026.

Analysts point to multiple catalysts that could unlock further value in 2026: scaling Methodiq to 200,000 subscribers by year-end, launching two additional niche brands in the wellness segment, and expanding international e-commerce operations into Europe and Asia. Oddity’s ability to monetize first-party data and maintain high gross margins could drive annual revenue growth above 50% for the next two years, while its streamlined cost structure may lift adjusted EBITDA margins toward 25% by Q4 2026.